Literature DB >> 23503802

The poor use of methadone in Italian hospices.

Sebastiano Mercadante1, Alessandro Valle, Cristina Agnelotti, Amanda Caruselli.   

Abstract

PURPOSE: A hospice may provide an ideal setting to use methadone because of a more protective environment in comparison with a home care setting, where it is seldom used. The aim of this survey was to investigate the frequency of the use of methadone in Italian hospices and how it is used.
METHODS: The Italian registry of palliative care institutions, named Osservatorio Federazione cure palliative, was consulted at its official website. Phone interviews were planned with physicians who were delegated to provide the answers. Data regarding the hospice and experience of physicians were collected. Questions regarding the attitudes in using methadone were posed, including the frequency of use and how this drug was used.
RESULTS: Of 165 centers contacted, information was available for 138 hospices (83.6 %). The majority of interviewed physicians considered methadone as a difficult drug to use, and only 38 responders (27.5 %) were using methadone as an analgesic in a minority of patients (less than 5 % in more than half of responders). When methadone is used as first opioid, all the patients receive less than 10 mg/day. Almost all physicians switched from morphine to methadone and used a conversion ratio inversely proportional to the morphine dose.
CONCLUSIONS: Physicians working in hospices should improve the knowledge regarding the use of opioids, including methadone, as well as complex treatments which can be the principal reason for hospice admission.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503802     DOI: 10.1007/s00520-013-1785-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  21 in total

Review 1.  Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

Authors:  Augusto Caraceni; Geoffrey Hanks; Stein Kaasa; Michael I Bennett; Cinzia Brunelli; Nathan Cherny; Ola Dale; Franco De Conno; Marie Fallon; Magdi Hanna; Dagny Faksvåg Haugen; Gitte Juhl; Samuel King; Pål Klepstad; Eivor A Laugsand; Marco Maltoni; Sebastiano Mercadante; Maria Nabal; Alessandra Pigni; Lukas Radbruch; Colette Reid; Per Sjogren; Patrick C Stone; Davide Tassinari; Giovambattista Zeppetella
Journal:  Lancet Oncol       Date:  2012-02       Impact factor: 41.316

2.  Methadone initiation and rotation in the outpatient setting for patients with cancer pain.

Authors:  Henrique A Parsons; Maxine de la Cruz; Badi El Osta; Zhijun Li; Bianca Calderon; J Lynn Palmer; Eduardo Bruera
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

3.  Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.

Authors:  E Bruera; J Pereira; S Watanabe; M Belzile; N Kuehn; J Hanson
Journal:  Cancer       Date:  1996-08-15       Impact factor: 6.860

Review 4.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

Review 5.  Palliative care in Italy: problem areas emerging from the literature.

Authors:  S Mercadante; V Vitrano
Journal:  Minerva Anestesiol       Date:  2010-07-08       Impact factor: 3.051

6.  Methadone and the hospice patient: prescribing trends in the home-care setting.

Authors:  Douglas J Weschules; Jill A McMath; Rollin Gallagher; Calvin J Alt; Calvin H Knowlton
Journal:  Pain Med       Date:  2003-09       Impact factor: 3.750

7.  Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.

Authors:  Sebastiano Mercadante; Giampiero Porzio; Patrizia Ferrera; Fabio Fulfaro; Federica Aielli; Lucilla Verna; Patrizia Villari; Corrado Ficorella; Vittorio Gebbia; Salvatore Riina; Alessandra Casuccio; Salvatore Mangione
Journal:  Eur J Pain       Date:  2008-03-18       Impact factor: 3.931

8.  Opioid switching in patients with advanced cancer followed at home. A retrospective analysis.

Authors:  Sebastiano Mercadante; Alessandro Valle; Giampiero Porzio; Flavio Fusco; Federica Aielli; Claudio Adile; Alessandra Casuccio
Journal:  J Pain Symptom Manage       Date:  2012-10-25       Impact factor: 3.612

9.  Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.

Authors:  Eduardo Bruera; J Lynn Palmer; Snezana Bosnjak; Maria Antonieta Rico; Jairo Moyano; Catherine Sweeney; Florian Strasser; Jie Willey; Mariela Bertolino; Clarissa Mathias; Odette Spruyt; Michael J Fisch
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

10.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

Authors:  C Ripamonti; L Groff; C Brunelli; D Polastri; A Stavrakis; F De Conno
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

View more
  1 in total

1.  Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.

Authors:  Gabriela P Peirano; Guillermo P Mammana; Mariela S Bertolino; Tania Pastrana; Gloria F Vega; Jorgelina Russo; Gabriela Varela; Ernesto Vignaroli; Raúl Ruggiero; Arnaldo Armesto; Gabriela Camerano; Graciela Dran
Journal:  Support Care Cancer       Date:  2016-03-29       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.